Single Gene Preimplantation Genetic Diagnosis (PGD)
One single gene test delivers more.
If you and/or your partner are at risk of passing on an inherited genetic disorder, you can minimize the risk of passing on the disorder by using in-vitro fertilization (IVF) and Preimplantation Genetic Diagnosis, or PGD. To ensure the most accurate PGD results, Natera uses a proprietary technology called Parental Support™, which evaluates multiple genetic markers flanking the gene mutation, as well as the entire chromosome carrying a gene mutation. Parental Support also matches embryo samples to DNA samples taken from the parents to confirm that the DNA being tested is from the embryo, with results that are typically >99% accurate. All Natera single gene tests also screen for Trisomy 21, or Down syndrome, and you have the option of simultaneously adding screening of all of the rest of the chromosomes so that your doctor will be able to select the embryos for transfer that will improve your chances for implantation.
A single gene disorder is a genetic disease caused by a change, or mutation, in a particular gene, causing that gene to function improperly or not at all. Common single gene disorders include cystic fibrosis, hemophilia, and Tay-Sachs disease. Single gene PGD is a specialized laboratory test used during in vitro fertilization to test embryos for a specified genetic disease. This test will help your IVF doctor to determine which embryos are free of the particular genetic disease, so that they can be selected for transfer.
With single gene PGD from Natera, your doctor will be able to select the embryos free of the identified mutation, increasing the chance for a healthy pregnancy.